Shanghai MicroPort Medical (Group) Co., Ltd.

Clinical trials sponsored by Shanghai MicroPort Medical (Group) Co., Ltd., explained in plain language.

Now part of MicroPort Scientific Corporation 0853 HKEX

A Chinese medical device company specializing in interventional products.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Completed 1

New dissolvable stent could revolutionize heart disease treatment

Disease control Completed

This study tested a new device called Firesorb, a temporary scaffold that slowly releases medicine to keep heart arteries open and then dissolves over time. Researchers compared it to a standard permanent stent in 430 people with coronary artery disease. The goal was to see if th…

Sponsor: Shanghai MicroPort Medical (Group) Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 13:00 UTC

Shanghai MicroPort Medical (Group) Co., Ltd.

New dissolvable stent could revolutionize heart disease treatment